Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.96 USD | -12.14% | -12.31% | +232.87% |
Jun. 07 | COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says | RE |
Jun. 06 | S&P 500, Nasdaq dip on the eve of US payrolls data | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+232.87% | 2.55B | |
+49.37% | 57.87B | |
+41.65% | 40.25B | |
-6.81% | 39.94B | |
-5.96% | 28.54B | |
+13.18% | 26.4B | |
-19.81% | 19.33B | |
+31.77% | 12.4B | |
+0.56% | 12.23B | |
+25.16% | 12.2B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi